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ABSTRACT 
Objective: The objective of this selective EBM review is to determine whether or not “Is ginger 
an effective treatment for reducing the severity of chemotherapy-induced nausea in breast cancer 
patients?” 
Study Design: The systematic review of three English language, peer reviewed, randomized 
control trials have been published between 2015 and 2016.  
Data Sources: Three randomized control trials were obtained using the PubMed database. One 
single-blind randomized control trial, one double-blinded randomized control trial, and one 
double-blind Phase II-III randomized control trial.  
Outcomes Measured: The participants of the trials graded the severity of nausea after the 
intervention of ginger or the control. Each study assessed patient-oriented outcomes. The 
outcomes measured were analyzed via visual analog scale7,8, European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaire8, and self-reported severity of 
nausea questionnaire6.  
Results: All three studies did not show a significant improvement in the severity of nausea in 
breast cancer patients receiving chemotherapy after the treatment of ginger. However, one study 
showed a positive benefit in the health-related quality of life after using ginger essential oil 
aromatherapy.  
Conclusion: The three randomized control trials used in this systematic review did not show an 
improvement in the severity of chemotherapy-induced nausea when using ginger as a treatment 
intervention. There were too many limitations determined in the three control trials which could 
have cause insignificant results. Although, participants in the single-blinded control trial reported 
positive improvement in the health-related quality of life.  
Keywords: Nausea, Chemotherapy, Ginger 
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INTRODUCTION 
 Chemotherapy-induced nausea (CIN) is a common and stressful acute side effect to 
pharmacologic treatment of cancer. Nausea is a feeling that is subjective and causes disturbance 
to the digestive tract. Therefore, nausea is a distressing sensation that is typically felt in the 
posterior pharynx or epigastrium. The onset of nausea has been found to be acute or delayed 
depending upon the chemotherapy drug.1 Acute nausea is likely to occur within 24 hours of 
administration of chemotherapy, while delayed nausea is defined to occur more than 24 hours 
after administration of chemotherapy.1 This side effect of chemotherapy drugs provokes a major 
impact on the lives of cancer patients. This systematic review evaluates the efficacy of ginger as 
a nonpharmacological treatment to chemotherapy-induced nausea.  
 According to the National Cancer Institute, the prevalence of CIN occurs in 80% of 
cancer patients.1 This common side effect needs to be managed and monitored medically. Cancer 
patients are managed by a medical team, one which includes physician assistants (PAs). As of 
2017, there were 1355 PAs with a career in oncology.2 Out of that number, 70.5% of those PAs 
provided services for diagnosis, treatment, and management of cancer as a chronic illness.2   
Chemotherapy can treat many cancers, however this systematic review analyzed studies 
involving breast cancer patients. As of 2012, there were 3 million women living with breast 
cancer in America which all require healthcare visits.3 Each healthcare visit has a cost and the 
exact cost of treatment depends on the stage of cancer. The stages include 0, I, II, III, and IV 
which can cost anywhere from $71,909 to $182,655 for treatment.3 Overall, the cost is higher for 
patients with an advanced cancer at diagnosis.3 
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There has been significant progress at understanding the cause of CIN. The sensation of 
nausea is controlled neurologically by the central nervous system, specifically autonomic 
nerves.1 It is known that areas of the brain such as the cerebral cortex, limbic system, activation 
of chemoreceptor trigger zones, and the vestibular-labyrinethine are all involved in producing a 
nauseous sensation.1 It is known that the dose, route of administration, and schedule of 
chemotherapy drugs all can contribute to CIN.4 In addition, patients younger than 50 years old, 
women, a history of alcohol abuse, and history of motion sickness are more likely to experience 
CIN.1 While cancer does not have a definite cure, patients will need to receive a chemotherapy 
depending on the severity of the cancer and it is possible to experience nausea a side effect.  
 The treatment of CIN is classically managed with pharmacologic therapies known as 
anti-emetics. This group of drugs work by blocking specific neurotransmitters that are otherwise 
known to activate the chemoreceptor trigger zones. Some of the neurotransmitters include 
serotonin, histamine, acetylcholine, and dopamine.1 Medications to treat CIN include 
ondansetron, granisetron, metoclopramide, and dexamethasone.1 Many anti-emetic drugs are 
used in combination depending upon how high the risk that nausea will be produced by the 
chemotherapy drug. Anti-emetic medications can be administered via oral pills, parenteral 
injection, transdermal patch, and rectal suppository.  
This systematic review analyzes three randomized control trials that use ginger as a non-
pharmalogical treatment for CIN to improve patients’ quality of life. Ginger is considered to be 
used as a natural alternative to relieve CIN in patients that do not desire pharmalogical drugs or 
patients who are resistant to those drugs. Ginger is a form of herbal therapy that has been used 
for thousands of years in cultures such as ancient China and India.5 This earth-produced plant has 
been used in studies to treat cancer, diabetes mellitus, inflammation, vomiting, and nausea.5 
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OBJECTIVE 
The objective of this EBM review it to determine whether or not “Is ginger an effective 
treatment for reducing the severity of chemotherapy-induced nausea in breast cancer patients?” 
METHODS 
The studies used in this systematic review are all randomized control trials found on 
PubMed. The population of all three studies included female patients diagnosed with breast 
cancer who experienced nausea as a symptom caused by chemotherapy. The patient population 
included in the studies were over 18 years old. The intervention used in all the studies was 
ginger. Ansari et Al. and Thamlikitikul et Al. both used a 500-mg ginger capsule.6,7 However, 
Lua et Al. used ginger aromatherapy.8 The comparison group in all studies used a visually 
matched placebo as the control. The outcome measured was determined by the efficacy of ginger 
by rating the severity of nausea and determining the health-related quality of life.  
 The key words used during the research of this systematic review included “ginger”, 
“nausea”, “chemotherapy”, and “breast cancer”. The studies were all selected by pertinence of 
the clinical question from the PubMed database. Each study has been published in peer reviewed 
journals in the English language. The studies selected for this systematic review included 
outcomes that were patient-oriented. The inclusion criteria incorporated the studies needed to be 
randomized, controlled, blinded, published after 2010, and with patient oriented outcomes. The 
participants needed to be diagnosed with breast cancer, receiving chemotherapy, and 
experiencing nausea. The exclusion criteria included participants under the age of 18 and a 
diagnosis other malignancies. The statistics reported include ANOVA, p-value, RBI, ABI, and 
NNT. Table 1 consists of demographics and characteristics of the studies used in this review. 
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Table 1: Demographics & Characteristics of the studies in this systematic review  
 
Study Type # Pts Ages 
(yrs) 
Inclusion Criteria Exclusion Criteria W/D Interventions 
Ansari6 
(2016) 
Double-
Blind, 
Phase 
II-III, 
RCT 
150 48.6 
(25-79) 
-Diagnosed 
breast cancer 
-Receiving AC, 
CAF, TAC 
chemotherapy 
-At least 3 
chemotherapy 
cycles 
-History of previous 
malignancy or 
chemotherapy 
-History of another 
systematic disease, 
metastatic 
condition, or 
receiving antiemetic 
drugs 
31 500 mg ginger 
powder BID 
for 3 days  
Lua8 
 (2015) 
Single- 
blind 
RCT 
75 47.3 
±9.26 
-Women >18  
-Normal sense of 
small 
-Diagnosed with 
breast cancer and 
receiving 
chemotherapy 
-at least two 
chemotherapy 
courses 
remaining 
-Pts with other 
malignancies 
-Pts allergic to 
ginger, perfumes, or 
cosmetics  
-Pts undergoing 
radiation therapy  
15 Breathe deeply 
into 
aromatherapy 
necklace at 
least 3 times a 
day for at least 
3 periods of 2 
minutes 
Tham-
likitkul7 
(2017) 
Double-
blind 
RCT 
34 >18 
years 
old 
- >18 years old 
-diagnosed with 
breast cancer 
-experienced 
vomiting or 
nausea 
-received first 
cycle of 
chemotherapy 
-at least two 
cycles 
chemotherapy 
-Pregnant 
-Lactating 
-Nausea/ vomiting 
prior to 
chemotherapy 
-Bleeding diathesis 
-ginger allergy 
-concomitant 
treatment with other 
chemotherapy 
- other conditions 
that cause nausea/ 
vomiting  
1 500 mg ginger 
capsule BID 
for 5 days 
starting the 
first day of the 
second 
chemotherapy 
cycle  
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OUTCOMES MEASURED 
The outcomes measured in the systematic review used three randomized control trials 
that assessed patient oriented outcomes (POEMS). The control trials analyzed ginger as a 
treatment to manage nausea as a result of chemotherapy drugs. Lua et Al. used a visual analog 
scale (VAS) to measure the severity of nausea.8 Also, Lua et Al. measured participants health 
related quality of life (HRQoL) while experiencing CIN by the European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaires (EORTC QLQ-C30).8 Ansari 
et Al. used participant reported adverse events that occurred during the study period.6 
Thamlikitikul et Al. used a questionnaire to record severity which included a VAS.7   
RESULTS 
 This systematic review used three randomized control trials to determine if ginger could 
improve the severity of nausea produced by chemotherapy and enhance quality of life in breast 
cancer patients. Each trial evaluated the severity of nausea differently. There are two trials that 
contain dichotomous data and one trial that has continuous data.  
 Ansari et Al. studied 150 patients that were recently diagnosed with breast cancer and 
would receive chemotherapy in Iran. The participants were randomly separated by a radiation 
oncology resident into two groups of ginger (n=75) and control (n=75).6 The patients along with 
the attending oncologists were unaware of the content within the capsule. The inclusion and 
exclusion criteria of Ansari et Al. study is shown in Table 1. Participants in the experimental and 
control group were asked to consume two capsules every 12 hours for 3 days.6 The participants 
were instructed to self-record severity of nausea during each chemotherapy cycle. Nausea was 
graded by no nausea or nausea with three levels of severity. 
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At the conclusion of the study, 31 patients were not accounted for in the results.6 This 
group of patients did not properly record severity of nausea on most days. The participants forgot 
to record their symptoms and were excluded from the study. However, 119 participants were 
included in the experimental (n=57) and the control (n=62) with appropriate recordings of nausea 
severity.6 
 The results of Ansari et Al. study concluded that the intervention was not statistically 
significant. The author of this systematic review converted continuous data to dichotomous for 
the third cycle of chemotherapy results. The study gave the number of subjects that in the control 
arm and the ginger arm whom did not experience nausea. The control arm that scored 0 consisted 
of 20 out of 62 subjects.6 While the ginger arm scored 0 was 23 out of 57 subjects.6 RBI, ABI, 
and NNT are calculated in Table 2. For this treatment to show effectiveness, there would need to 
be 13 patients treated for 1 more patient to experience relief of nausea with a ginger intervention 
which is a small treatment effect. The study provided the mean nausea severity scores which was 
1.40 for ginger and 1.42 for control that produced a difference of 0.02 between the ginger and 
placebo.6 This result showed nausea was more severe in the ginger arm however, this is not 
considered significant.6  
Table 2: Calculation for treatment of Ansair et Al.6 
Study CER EER RBI ABI NNT 
Ansari et Al. 32% 40% 25% 8% 13 
Thamlikitkul et Al. double-blind study consisted of only 34 participants and the study 
was conducted in Thailand. Each participant was assigned to a group by a stratified 
randomization table.7 The study consisted of a ginger group (n=19) and control group (n=15).7 
However, the groups were switched
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in the next cycle of chemotherapy to receive the opposite intervention. Although one participant 
did not fully complete the intervention, no participants were excluded from the study.7 The 
intervention of Thamlikitkul et Al. consisted of participants consuming a 500-mg ginger capsule 
or placebo twice a day for five days which stated on the first day of the chemotherapy cycle.7 
The participants of this study were prophylactically treated with anti-emetics and were allowed 
to use rescue anti-emetics if symptoms became intolerable.7  
The results of Thamlikitkul et Al. study found that the primary outcome of that study was 
not a significant difference between the ginger and the control.7 The data from this study was 
presented as continuous and not able to be converted to dichotomous. Thamlikitkul et Al. 
collected data via VAS and presented the data as a change in mean from the baseline7. The study 
used ANOVA test to determine the difference in nausea score. The results of the study are 
represented in Table 3. The interpretation of the results displays a mean nausea score of 3 with a 
small treatment effect of this trial.7 There showed no significance difference of acute or delayed 
nausea in both arms of the study.7 
Table 3: Thamlikitkul et Al. study that used ginger used as a treatment for CIN in 
comparison to a placebo of the primary outcome7 
Thamlikitkul et Al. CI P value 
Ginger vs. Control rating 
severity of nausea 
95%, -3 to 9 p=0.30 
Lua et Al. enrolled 75 participants that were diagnosed with breast cancer and receiving 
chemotherapy into a single-blind study which took place in Malaysia.8 The subjects were 
randomized into two groups by using a technique known as block randomization 1:1 ratio.8 The 
inclusion and exclusion criteria of this study is displayed in Table 1. The placebo group consisted 
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of 37 participants and the ginger intervention group consisted on 38 participants.8 The 
intervention of Lua et Al. study used ginger essential oil to treat CIN. In the comparison group, 
the placebo was a fragranced matched oil. Participants were instructed to wear a necklace for 5 
days and breathe deeply three times a day with the oil bottle under the nose for 2-minute 
duration.8 The groups interventions were crossed over to the opposite intervention on the second 
round of chemotherapy. Lua et Al. collected data by providing a VAS for the participants to 
record the severity of nausea within a diary. The participants were instructed to self-record 
severity of nausea three times a day, 9 am, 3 pm, and 9 pm respectively.8 At the end of the study, 
a total of 60 participants from each group were accounted for in the results of the study with 30 
subjects in each arm.8 
 The results of Lua et Al. determined that the treatment of ginger essential oil showed no 
significant difference on the VAS score of nausea.8 The results were presented in continuous 
data in the trial and could not be converted to dichotomous. Lua et Al. reported five days of data 
via ANOVA to determine the difference in severity of nausea between the two interventions.8 
The results are displayed in Table 4 of this systematic review.  The interpretation of the results 
shows a mean difference of 1.83 between the essential oil and fragranced oil which is a small 
treatment effect.8 
Table 4: Ginger as an essential oil vs. a fragranced oil for the treatments of CIN 
Study: Lua et Al. F stat P value 
Ginger Essential oil vs. 
fragranced oil 
F (1, 58) = 1.82 P=0.183 
Lua et Al. used a patient oriented questionnaire to determine the HRQoL profile of the 
breast cancer participants. The questionnaire EORTC QLQ-30 analyzed five areas of functioning
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and eight symptoms associated with chemotherapy cycles.8 Specifically, nausea and vomiting 
were grouped together on the HRQoL scale. The results showed a significant difference of 
reduction in symptoms while participants were using the ginger essential oil intervention.8 The 
results reported a p < 0.001 which is significant8.  
 Ginger as a treatment intervention was well tolerated across all studies. Participants in all 
of the studies did not have any negative reactions to ginger.  
DISCUSSION 
Chemotherapy is a treatment for cancer and it can produce nausea as a side effect that can 
decrease the quality of life in patients. This selective EBM systematic review analyzed whether 
or not ginger is an effective treatment to reduce the severity of nausea cause by chemotherapy. 
All three randomized control trials evaluated in this review showed ginger is not a significant 
treatment for CIN. However, the HRQoL profile measured in the study produced by Lua et Al. 
showed an increase of the quality of life in patients experiencing nausea and vomiting as a 
symptom produced by chemotherapy.  
 Ginger has been used traditionally for centuries and it can be easily found in markets 
across the globe.5 The earth-produced plant rarely causes adverse reactions unless it is consumed 
in in large doses.5 The recommended dosing for nausea is ranged between 250 mg to 2 grams a 
day divided over three to four times a day.5 Ginger has the potential for interaction with 
medications such as anti-platelets, anticoagulants, antihypertensive, hypoglycemic agents, 
nonsteroidal anti-inflammatory drugs, salicylates, and thrombolytic agents.5 However, there are 
no contraindications identified for individuals using ginger.5  
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This systematic review used three randomized control trials to determine if ginger can 
improve nausea as a side effect to patients receiving chemotherapy. Although each trial found 
data with insignificant results, it does not exclude ginger as a treatment. This non-pharmalogical 
treatment should not be excluded because there were many limitations to the studies which could 
have manipulated the results. Therefore, it would be beneficial if future clinical trials used ginger 
with different parameters than the studies of this systematic review.  
Additionally, each study contained limitations which include population size, time 
period, and recording of symptoms. Thamlikitkul et Al. study was limited by the sample size 
which consisted of only 34 participants.7 In the next study conducted by Ansari et Al., the time 
period of treatment only lasted for 3 days.6 It is possible that ginger needs a longer treatment 
time to see a decrease in nausea severity. Finally, the study conducted by Lua et Al. allowed 
patients to self-record symptoms which could have skewed the results of the study.8 It would be 
more accurate with computers tracking when patients record their symptoms.  
 Another limiting factor, each study used in the review was conducted within another 
country outside of the United States. These countries include Iran, Thailand, and Malaysia. The 
standards in these countries may not be consistent with those in America which puts a limitation 
of the results. Therefore, the standards of treatment within the United States could possibly 
change the results if future trials are conducted here. 
The final limitation includes prophylactic treatment of CIN with anti-emetic medications 
to the participants in the study. Although medical practice does not inflict harm on patients that 
seek treatment, the administration of anti-emetics prior to chemotherapy could have influenced 
the results. In the studies conducted by Thamlikitkul et Al. and Lua et Al., the participants were 
prophylactically treat with anti-emetics.7,8 
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CONCLUSION 
 The evidence evaluated in this systematic review found that ginger is not effective at 
improving the severity of nausea produced by chemotherapy. The study conducted by Lua et Al. 
found that the health-related quality of life showed significant improvement of nausea and 
vomiting (p < 0.001) by ginger essential oil aromatherapy via the European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaire.8 However, each of the control 
trials did not find any significant improvement to the severity of nausea during the intervention 
compared to the control group. Since there are multiple limitations to these control trials, ginger 
as a treatment for CIN should not be excluded as a for a future intervention. New research trials 
to investigate the potential of ginger would benefit by being conducted in America, a larger 
sample size, a longer treatment interval, and a strict recording of symptoms. 
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